Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Ascend Laboratories, LLC recalls Rizatriptan Benzoate Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
Products
  • Rizatriptan Benzoate Tablets
Where it was sold

US Nationwide.

Nationwide

Units affected
N/A
About this recall
Rizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ 07054, NDC 67877-261-18